TAOWANGTAO WANG0.000000000000000.000000000000005922WANG, TAOAssociate Professorplugins:TwitterTwitterprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:pluginSearchableDataProfilesRNS Plugin Searchable Dataprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:orcidIdORCID idvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonBreast Medical OncologyGynecological Oncology & Reproductive MedicineInvestigational Cancer TherapeuticsLeukemiaMD AndersonHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorKELLY KHUNTKELLY K HUNT8555HUNT, KELLY KProfessorROBERTCOLEMANROBERT COLEMAN9184COLEMAN, ROBERTProfessorFUNDAMERIC-BERNSTAMFUNDA MERIC-BERNSTAM8778MERIC-BERNSTAM, FUNDAProfessorAMAN UBUZDARAMAN U BUZDAR8609BUZDAR, AMAN UProfessorAuthorship 2812603Authorship 2812614Authorship 2812626Authorship 2812636Authorship 2812643Authorship 281265374Professor10Assistant Professor54Instructor14Associate Professor42DirectorBreast Surgical OncologyAMANDAROSEWELL SHAWAMANDA ROSEWELL SHAW0.000000000000000.000000000000004995ROSEWELL SHAW, AMANDAAssistant Professor18829545Kang YK, Schiff R, Ko L, Wang T, Tsai SY, Tsai MJ, O'Malley BWCancer researchDual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis. Cancer Res. 2008 Oct 01; 68(19):7887-96.Cancer Res2008-10-01T00:00:002008Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis.18952980Barahmani N, Carpentieri S, Li XN, Wang T, Cao Y, Howe L, Kilburn L, Chintagumpala M, Lau C, Okcu MFNeuro-oncologyGlutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma. Neuro Oncol. 2009 Jun; 11(3):292-300.Neuro Oncol2008-10-24T00:00:002008Glutathione S-transferase M1 and T1 polymorphisms may predict adverse effects after therapy in children with medulloblastoma.19813253Sprehe MR, Barahmani N, Cao Y, Wang T, Forman MR, Bondy M, Okcu MFPediatric blood & cancerComparison of birth weight corrected for gestational age and birth weight alone in prediction of development of childhood leukemia and central nervous system tumors. Pediatr Blood Cancer. 2010 Feb; 54(2):242-9.Pediatr Blood Cancer2010-02-01T00:00:002010Comparison of birth weight corrected for gestational age and birth weight alone in prediction of development of childhood leukemia and central nervous system tumors.21224735Plon SE, Cooper HP, Parks B, Dhar SU, Kelly PA, Weinberg AD, Staggs S, Wang T, Hilsenbeck SGenetics in medicine : official journal of the American College of Medical GeneticsGenetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med. 2011 Feb; 13(2):148-54.Genet Med2011-02-01T00:00:002011Genetic testing and cancer risk management recommendations by physicians for at-risk relatives.21447808Barone I, Brusco L, Gu G, Selever J, Beyer A, Covington KR, Tsimelzon A, Wang T, Hilsenbeck SG, Chamness GC, And? S, Fuqua SAJournal of the National Cancer InstituteLoss of Rho GDIa and resistance to tamoxifen via effects on estrogen receptor a. J Natl Cancer Inst. 2011 Apr 06; 103(7):538-52.J Natl Cancer Inst2011-03-29T00:00:002011Loss of Rho GDIa and resistance to tamoxifen via effects on estrogen receptor a.21785360McGuire AL, Oliver JM, Slashinski MJ, Graves JL, Wang T, Kelly PA, Fisher W, Lau CC, Goss J, Okcu M, Treadwell-Deering D, Goldman AM, Noebels JL, Hilsenbeck SGGenetics in medicine : official journal of the American College of Medical GeneticsTo share or not to share: a randomized trial of consent for data sharing in genome research. Genet Med. 2011 Nov; 13(11):948-55.Genet Med2011-11-01T00:00:002011To share or not to share: a randomized trial of consent for data sharing in genome research.22213783Oliver JM, Slashinski MJ, Wang T, Kelly PA, Hilsenbeck SG, McGuire ALPublic health genomicsBalancing the risks and benefits of genomic data sharing: genome research participants' perspectives. Public Health Genomics. 2012; 15(2):106-14.Public Health Genomics2011-12-30T00:00:002011Balancing the risks and benefits of genomic data sharing: genome research participants' perspectives.22706629Cerne JZ, Zong L, Jelinek J, Hilsenbeck SG, Wang T, Oesterreich S, McGuire SEBreast cancer research and treatmentBRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients. Breast Cancer Res Treat. 2012 Aug; 135(1):135-43.Breast Cancer Res Treat2012-06-16T00:00:002012BRCA1 promoter methylation status does not predict response to tamoxifen in sporadic breast cancer patients.23582504Wolfswinkel EM, Lopez SN, Weathers WM, Qashqai S, Wang T, Hilsenbeck SG, Rimawi MF, Heller LJournal of plastic, reconstructive & aesthetic surgery : JPRASPredictors of post-mastectomy reconstruction in an underserved population. J Plast Reconstr Aesthet Surg. 2013 Jun; 66(6):763-9.J Plast Reconstr Aesthet Surg2013-04-10T00:00:002013Predictors of post-mastectomy reconstruction in an underserved population.18300322Raphael JL, Kamdar A, Wang T, Liu H, Mahoney DH, Mueller BUPediatric blood & cancerDay hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease. Pediatr Blood Cancer. 2008 Sep; 51(3):398-401.Pediatr Blood Cancer2008-09-01T00:00:002008Day hospital versus inpatient management of uncomplicated vaso-occlusive crises in children with sickle cell disease.19920204Chen L, Mayer JA, Krisko TI, Speers CW, Wang T, Hilsenbeck SG, Brown PHCancer researchInhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells. Cancer Res. 2009 Dec 01; 69(23):8853-61.Cancer Res2009-11-17T00:00:002009Inhibition of the p38 kinase suppresses the proliferation of human ER-negative breast cancer cells.19998099McGuire AL, Diaz CM, Wang T, Hilsenbeck SGThe American journal of bioethics : AJOBSocial networkers' attitudes toward direct-to-consumer personal genome testing. Am J Bioeth. 2009; 9(6-7):3-10.Am J Bioeth2009-01-01T00:00:002009Social networkers' attitudes toward direct-to-consumer personal genome testing.20187096Kilburn L, Okcu MF, Wang T, Cao Y, Renfro-Spelman A, Aldape KD, Gilbert MR, Bondy MCancerGlutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients. Cancer. 2010 May 01; 116(9):2242-9.Cancer2010-05-01T00:00:002010Glutathione S-transferase polymorphisms are associated with survival in anaplastic glioma patients.21177763Litzenburger BC, Creighton CJ, Tsimelzon A, Chan BT, Hilsenbeck SG, Wang T, Carboni JM, Gottardis MM, Huang F, Chang JC, Lewis MT, Rimawi MF, Lee AVClinical cancer research : an official journal of the American Association for Cancer ResearchHigh IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy. Clin Cancer Res. 2011 Apr 15; 17(8):2314-27.Clin Cancer Res2010-12-22T00:00:002010High IGF-IR activity in triple-negative breast cancer cell lines and tumorgrafts correlates with sensitivity to anti-IGF-IR therapy.21465171Dhar SU, Cooper HP, Wang T, Parks B, Staggs SA, Hilsenbeck S, Plon SEBreast cancer research and treatmentSignificant differences among physician specialties in management recommendations of BRCA1 mutation carriers. Breast Cancer Res Treat. 2011 Aug; 129(1):221-7.Breast Cancer Res Treat2011-04-05T00:00:002011Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.23569315Rimawi MF, Mayer IA, Forero A, Nanda R, Goetz MP, Rodriguez AA, Pavlick AC, Wang T, Hilsenbeck SG, Gutierrez C, Schiff R, Osborne CK, Chang JCJournal of clinical oncology : official journal of the American Society of Clinical OncologyMulticenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006. J Clin Oncol. 2013 May 10; 31(14):1726-31.J Clin Oncol2013-04-08T00:00:002013Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.Authorship 840581121994209Wang TI, Wu PK, Chen CF, Chen WM, Yen CC, Hung GY, Liu CL, Chen THJapanese journal of clinical oncologyThe prognosis of patients with primary osteosarcoma who have undergone unplanned therapy. Jpn J Clin Oncol. 2011 Nov; 41(11):1244-50.Jpn J Clin Oncol2011-10-11T00:00:002011The prognosis of patients with primary osteosarcoma who have undergone unplanned therapy.true1InstructorInstructortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorD020360Procedures66449650.385167Neoadjuvant TherapyD033181Activities & Behaviors1572730.786733Information DisseminationD001943Disorders1432156510.17611Breast NeoplasmsD012516Disorders3209250.581559OsteosarcomaD018931Chemicals & Drugs2918400.662962Antineoplastic Agents, HormonalDepartment of MedicineDepartment of PediatricsDuncan Cancer CenterMedicine-General MedicineMedicine-Hematology & OncologyCancer CenterPediatrics-OncologyBaylor College of MedicineKANGLIUKANG LIU0.000000000000000.000000000000001707LIU, KANGInstructorMARTHAMIMSMARTHA MIMS0.000000000000000.000000000000003036MIMS, MARTHAProfessorMEHMETOKCUMEHMET OKCU0.000000000000000.00000000000000438OKCU, MEHMETProfessorSUSANHILSENBECKSUSAN HILSENBECK0.000000000000000.000000000000003634HILSENBECK, SUSANProfessorBINUMICHAELBINU MICHAEL0.000000000000000.000000000000004163MICHAEL, BINUAssistant ProfessorMOTHAFFARRIMAWIMOTHAFFAR RIMAWI0.000000000000000.000000000000002107RIMAWI, MOTHAFFARProfessorSHARONPLONSHARON PLON0.000000000000000.000000000000003410PLON, SHARON0000-0002-9626-0936ProfessorAMYMCGUIREAMY MCGUIRE29.71073630000000-95.39660450000000417MCGUIRE, AMYProfessor23883229Ortiz-Perez T, Trevino EJ, Sepulveda KA, Hilsenbeck SG, Wang T, Sedgwick ELAJR. American journal of roentgenologyDoes formal instruction about the BI-RADS ultrasound lexicon result in improved appropriate use of the lexicon? AJR Am J Roentgenol. 2013 Aug; 201(2):456-61.AJR Am J Roentgenol2013-08-01T00:00:002013Does formal instruction about the BI-RADS ultrasound lexicon result in improved appropriate use of the lexicon?24169421Robinson JO, Slashinski MJ, Wang T, Hilsenbeck SG, McGuire ALJournal of empirical research on human research ethics : JERHREParticipants' recall and understanding of genomic research and large-scale data sharing. J Empir Res Hum Res Ethics. 2013 Oct; 8(4):42-52.J Empir Res Hum Res Ethics2013-10-01T00:00:002013Participants' recall and understanding of genomic research and large-scale data sharing.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorOne Baylor PlazaHouston, 77030TX0.2624840.00410192239research areas0.6605870.021240835coauthor of10.74382.99460similar to1123selected publicationsZEYIZHENGZEYI ZHENG0.000000000000000.000000000000005923ZHENG, ZEYIInstructorhttp://www.texaschildrens.org/departments/cancer-genetics-clinic/our-teamTexas Children's Cancer Genetics Clinichttps://www.bcm.edu/people-search/sharon-plon-28865My Research Sitesplontrue1Assistant ProfessorAssistant Professortrue1InstructorInstructortrue1Assistant ProfessorAssistant ProfessorAuthorship 1333524Authorship 1334263Authorship 1335024Authorship 1335245Authorship 1338553Authorship 1340938Authorship 1341313Authorship 1341354Authorship 1343085Authorship 1348736Authorship 1349188Authorship 1357435Authorship 1365718Authorship 1367215Authorship 1374203Authorship 1376215true1Associate ProfessorAssociate Professor2Associate ProfessorAssociate ProfessorTwitter @mfrimawihttps://www.texaschildrens.org/find-a-doctor/sharon-e-plon-md-phd-facmgTexas Children's Hospital Profiletrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessor24395789Hatcher RJ, Dong J, Liu S, Bian G, Contreras A, Wang T, Hilsenbeck SG, Li Y, Zhang PProceedings of the National Academy of Sciences of the United States of AmericaPttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis. Proc Natl Acad Sci U S A. 2014 Jan 21; 111(3):1008-13.Proc Natl Acad Sci U S A2014-01-06T00:00:002014Pttg1/securin is required for the branching morphogenesis of the mammary gland and suppresses mammary tumorigenesis.24554387Morrison G, Fu X, Shea M, Nanda S, Giuliano M, Wang T, Klinowska T, Osborne CK, Rimawi MF, Schiff RBreast cancer research and treatmentTherapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance. Breast Cancer Res Treat. 2014 Apr; 144(2):263-72.Breast Cancer Res Treat2014-02-20T00:00:002014Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance.25317207Scollon S, Bergstrom K, Kerstein RA, Wang T, Hilsenbeck SG, Ramamurthy U, Gibbs RA, Eng CM, Chintagumpala MM, Berg SL, McCullough LB, McGuire AL, Plon SE, Parsons DWGenome medicineObtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients. Genome Med. 2014; 6(9):69.Genome Med2014-09-17T00:00:002014Obtaining informed consent for clinical tumor and germline exome sequencing of newly diagnosed childhood cancer patients.25378456Niravath P, Tham YL, Wang T, Rodriguez A, Foreman C, Hilsenbeck SG, Elledge R, Rimawi MThe oncologistA phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer. Oncologist. 2015 Jan; 20(1):13.Oncologist2014-11-06T00:00:002014A phase II trial of capecitabine concomitantly with whole-brain radiotherapy followed by capecitabine and sunitinib for brain metastases from breast cancer.